We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ALPN market cap is 3.75B. The company's latest EPS is USD -0.5540 and P/E is -116.55.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 8.37M | 2.78M | 9.39M | 8.59M | 10.04M |
| Operating Income | -13.83M | -20.37M | -15.59M | -15.66M | -14.55M |
| Net Income | -13.27M | -18.86M | -13.27M | -13.16M | -11.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.74M | 9.34M | 23.44M | 30.06M | 58.88M |
| Operating Income | -43.57M | -28.75M | -49.86M | -58.15M | -44.25M |
| Net Income | -41.85M | -27.94M | -50.33M | -57.76M | -32.18M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 291.6M | 286.69M | 262.1M | 252.84M | 240.55M |
| Total Liabilities | 109.59M | 107.27M | 92.56M | 83.45M | 78.92M |
| Total Equity | 182.01M | 179.42M | 169.54M | 169.39M | 161.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 54.09M | 144.09M | 255.9M | 286.69M | 379.85M |
| Total Liabilities | 24.62M | 81.93M | 135M | 107.27M | 51.91M |
| Total Equity | 29.47M | 62.16M | 120.9M | 179.42M | 327.94M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -26.97M | -43.75M | -26.15M | -44.24M | -60.04M |
| Investing | -5.45M | -113.35M | 28.35M | 57.68M | 57.14M |
| Financing | 91.15M | 102.69M | -1.09M | 7.31M | 8.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -35.35M | 30.08M | -15.25M | -43.75M | -79.01M |
| Investing | 16.76M | -72.82M | -52.48M | -113.35M | -55.56M |
| Financing | 24.26M | 61.38M | 100.76M | 102.69M | 165.12M |
| Market Cap | 3.75B |
| Price to Earnings Ratio | -116.55 |
| Price to Sales Ratio | 63.72 |
| Price to Cash Ratio | 85.41 |
| Price to Book Ratio | 11.44 |
| Dividend Yield | - |
| Shares Outstanding | 58.1M |
| Average Volume (1 week) | 2.37M |
| Average Volume (1 Month) | 4.47M |
| 52 Week Change | 815.74% |
| 52 Week High | 64.70 |
| 52 Week Low | 6.71 |
| Spread (Intraday) | 0.14 (0.22%) |
| Company Name | Alpine Immune Sciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.alpineimmunesciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
